Attached files
| file | filename |
|---|---|
| EX-99 - PRESS RELEASE - Youngevity International, Inc. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of
Report (date of earliest event reported): May 14, 2020
YOUNGEVITY INTERNATIONAL, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
001-38116
|
|
90-0890517
|
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File No.)
|
|
(IRS
Employer Identification No.)
|
2400 Boswell Road, Chula Vista, CA 91914
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (619) 934-3980
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
☐ Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common
Stock
|
YGYI
|
The
Nasdaq Capital Market
|
|
Series
D Preferred Stock
|
YGYIP
|
The
Nasdaq Capital Market
|
Indicate
by check mark whether the registrant is an emerging growth company
as defined in in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this
chapter).
Emerging
growth company ☐
If an
emerging growth company, indicate by checkmark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange
Act. ☐
Item 3.01. Notice of Delisting or Failure to Satisfy a
Continued Listing Rule or Standard; Transfer of
Listing.
On May
14, 2020, Youngevity International, Inc. (the
“Company”) received an additional notification letter
from the Listing Qualifications Department of The Nasdaq Stock
Market LLC (“Nasdaq”) indicating that as a result of
the Company’s failure to file its Quarterly Report on Form
10-Q for the period ended March 31, 2020 (the “Form
10-Q”) and Annual Report on Form 10-K for the year ended
December 31, 2019 (the “Form 10-K”), the Company does
not comply with Nasdaq’s continued listing requirements
as set forth in Nasdaq Listing Rule 5250(c)(1). As previously
reported on April 2, 2020, Nasdaq notified the Company that it did
not comply with its continued listing requirements as set forth in
Nasdaq Listing Rule 5250(c)(1) due to its failure to file its Form
10-K. In accordance with the Nasdaq letter dated April 2, 2020, the
Company has until June 1, 2020, to submit a plan to regain
compliance with Nasdaq’s continued listing requirements and
if Nasdaq accepts the plan, Nasdaq can grant an extension of up to
180 calendar days from the filing due date, of September 28, 2020,
to regain compliance. The Company can also regain compliance with
Nasdaq’s continued listing requirements at any time before
September 28, 2020, by filing the Form 10-K and Form 10-Q with the
Securities and Exchange Commission (the “SEC”), as well
as any subsequent periodic financial reports that may become
due.
The
Company’s management is working diligently to complete the
Form 10-K and Form 10-Q and intends to file each report as soon as
practicable.
Item 9.01 Financial Statements and
Exhibits.
|
(d)
|
Exhibits.
|
|
|
|
|
|
Exhibit 99.1 Press Release issued by
Youngevity International, Inc., dated May 18, 2020
|
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
YOUNGEVITY
INTERNATIONAL, INC.
|
|
|
|
|
Date:
May 18, 2020
|
By:
/s/ David
Briskie
|
|
|
Name:
David Briskie
|
|
|
Title:
President and Chief Financial Officer
|